COARE BIOTECHNOLOGY, INC.

Basic Information

800 RESEARCH PKWY
OKLAHOMA CITY, OK, 73104-3611

Company Profile

n/a

Additional Details

Field Value
DUNS: 963335570
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2


  1. Development of an ADC against Pancreatic Cancer

    Amount: $225,000.00

    DESCRIPTION provided by applicant Pancreatic ductal adenocarcinoma PDAC is one of the most devastating human cancers It is the fourth leading cause of cancer related deaths in the U S with a ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Development of ADC to Target Tumor Stem Cells In Colorectal Cancer

    Amount: $224,950.00

    DESCRIPTION provided by applicant Colorectal cancer CRC is the third leading cause of cancer related death in the U S Although advances in CRC screening surgical therapies and medical manageme ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  3. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $220,099.00

    DESCRIPTION (provided by applicant): Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor and is the fourth leading cause of cancer-related death in the U.S. The 5-year survival rate of its victim ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government